Introduction de Vexim sur NYSE Alternext

Back

Paris, 3 May 2012 – NYSE Euronext today announced the listing on NYSE Alternext in Paris of Vexim, a key player in innovative microsurgery for spinal trauma.

Founded in 2006 and based in Toulouse, Vexim specialises in minimally invasive treatment of vertebral compression fractures and has designed and developed SpineJack®, which it markets. This innovative technology consists of a 5-mm titanium implant that restores the crushed vertebrae’s initial height, volume and natural anatomy, and eliminates pain. The company currently employs 27 people and has an extensive distribution network in France and Germany.

Vexim (ticker code: ALVXM) was listed through admission to trading of 2,163,100 existing shares and 1,158,544 new shares issued under a Global Offering.[1]The Global Offering raised a total of €11 million.

The admission and issue price of Vexim shares was set at €9.50. Market capitalization stood at around €31.6 million on the day of listing.

We are delighted to welcome Toulouse-based Vexim to NYSE Alternext. Listing is a new an  important stage in its growth that will consolidate its reputation and raise the funds it needs to pursue investment in R&D,” said Marc Lefèvre, Head of European Coverage at NYSE Euronext. “NYSE Alternext is a perfect match for companies like Vexim that want to benefit from our European reach which attracts a rising number of investors and higher liquidity.

Vincent Gardès, CEO of Vexim, added: “We would like to thank all of the shareholders that have placed their trust in us and made this critical step a success, and who are now on board as we pursue our commercial development.”

In seven years, €2.7 billion has been raised on NYSE Alternext, half through secondary issues, by companies from countries including Belgium, Canada, China, France, Italy, Luxembourg, the Netherlands, Spain, the UK and the US. Their market capitalisation totals €6.2 billion. Today 183 companies are listed on NYSE Alternext.


[1]The Global Offering was made up of an Open Price Public Offering and a Global Placement with institutional investors in France and other countries.

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With close to 2,000 listed issuers and around €5.8 trillion in market capitalisation as of end June 2022, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2022, Euronext N.V. - All rights reserved.